NEW YORK (TheStreet) -- xG Technology (XGTI) was up 33.1% to $3.58 this afternoon after announcing that its cognitive radio software is ready for wide release. The wireless communications company had previously released its xMax broadband networking equipment on conditional availability to select consumers.
xG specializes in cognitive or smart radio technology that allows radio transceivers to pick up and use pockets of free spectrum within already purchased spectrum without disrupting their service and conforming to FCC standards.
"We are excited to release these enhanced capabilities to our customers' networks via over-the-air software updates," said John Coleman, CEO of xG Technology. "This underscores one of the core benefits of leveraging advanced software defined radio technology in xMax. It enables xG to rapidly deliver feature and capability updates via software-only rollouts, versus hardware upgrades and replacements required by competitive solutions."
Must read: Warren Buffett's 10 Favorite Stocks
Top 10 Warren Buffett Companies To Invest In 2014: Axxess Pharma Inc (AXXE)
Axxess Pharma Inc. is a pharmaceutical company. It is engaged in marketing of dermatological, therapeutic nutritionals, pain management, and diagnostic products in Canada and abroad. In October 2013, the Company announced that it has incorporated a wholly owned subsidiary AllStar HealthBrands Inc.
The Company various products include Britical Tablets, Gravergol Capsules, Lactrase Capsules, Somnol Tablets, Triferexx -150 Polysaccharide-iron complex, Urasal Granules, Axspaz Tablets, Vivol Tablets, Hydraxx Lotion, Kemsol Solution, Soropon shampoo, and Skin care Products. Its distribution network includes physicians, hospitals, Government and defense institutions, and pharmacies.
Advisors' Opinion:- [By Peter Graham]
Small cap healthcare and lifestyle stocks Axxess Pharma Inc (OTCMKTS: AXXE), Medefile International Inc (OTCMKTS: MDFI) and Intelligent Living Inc (OTCMKTS: ILIV) have all been getting some extra attention lately thanks in part to a few disclosed paid promotions or investor relations type of activities. But just how healthy are these small cap stocks for investors and traders alike? Here is a quick reality check:
Axxess Pharma Inc (OTCMKTS: AXXE) Has Been Busy With the Press ReleasesSmall cap Axxess Pharma is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. On Friday, Axxess Pharma fell 7.52% to $0.295 for a market cap of $12.46 million plus AXXE is down 88.8% over the past year and down 99.8% over the past five years in intermittent trading according to Google Finance.
- [By Peter Graham]
Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:
Top 10 Warren Buffett Companies To Invest In 2014: Burnham Holdings Inc (BURCA)
Burnham Holdings, Inc., incorporated on December, 2, 2002, is the parent company of the Burnham group of companies. The Company is a manufacturer of boilers, furnaces, radiators, air conditioning systems and related accessories for residential, commercial, and industrial applications. The Company has eight brand names, marketed through eight independent sales organizations that are differentiated by product line and markets served. The Burnham Hydronics, New Yorker, Governale, Thermo Pride, and Crown product lines offer a range of cast iron, stainless steel, aluminum, and steel boilers, cast iron and steel heat distribution products, warm air furnaces, heat pumps and central air conditioning systems for the residential heating and cooling market. Typical applications of these products are for all styles and sizes of homes and small buildings. The Burnham Commercial, Bryan Boilers, and Thermal Solutions product lines offer a range of cast iron, firetube, watertube, and copper tube boilers, as well as boiler room accessories for the commercial and industrial markets. Typical uses of these products are for heating large buildings and high-pressure steam generation for process applications.
The Burnham Foundry produces boiler castings for the affiliated manufacturing companies, as well as outside customers. Wendl and Manufacturing is a producer of both pressurized and non-pressurized tanks and vessels for liquid storage applications. Norwood Manufacturing is a manufacturer of painted light gauge metal parts. The Company sells to wholesale distributors who in turn, market to builders, heating contractors, utilities, and fuel dealers for resale to end-use customers.
Advisors' Opinion:- [By Marc Bastow]
Boiler, radiator, air conditioning and furnace manufacturer Burnham Holdings (BURCA) raised its quarterly dividend 11% to 21 cents per share, payable March 18 to shareholders of record as of March 11.
BURCA Dividend Yield: 4.3%
Top 10 Stocks To Buy Right Now: FLIR Systems Inc (FLIR)
FLIR Systems, Inc. (FLIR), incorporated on March 8, 1978, is a designer, manufacturer, and marketer of thermal imaging systems. The Company�� advanced sensors and integrated sensor systems enable the gathering and analysis of critical information through a range of applications in commercial, industrial, and government markets worldwide. Its business is organized into two divisions: Commercial Systems and Government Systems. Commercial Systems division includes Thermal Vision & Measurement and Raymarine. Government Systems division include Surveillance, Detection, and Integrated Systems. It offers a range of sensor products, including infrared imaging cameras and systems, detector cores, CBRNE threat detectors, test and measurement instruments, radars, maritime electronics, and related products and solutions. On December 20, 2012, the Company acquired Lorex Technology Inc. In December 2012, the Company acquired Traficon International NV. In August 2013, Tessera Technologies Inc announced that FLIR Systems, Inc. acquired a portion of the assets of Tessera's Micro-Optics business based in Charlotte, North Carolina.
Thermal Vision & Measurement
Thermal Vision & Measurement (TVM) products are generally sold for applications where the customer need is to see at night or in adverse conditions or to image a scene while gathering valuable situational and temperature information. The Company�� infrared sensors business, which sells focal plane arrays and camera cores internally, as well as to third parties on an original equipment manufacturer (OEM) basis, is also part of TVM. Its thermal and visible light security products are used to protect critical infrastructure, ports, borders, commercial sites, and residential homes. The Company offers a night vision system for passenger automobiles that provides drivers with the ability to see at night and through obscurants, such as fog, at distances much further and wider than can be seen with traditional headlights. As of December 31, ! 2012, provide camera cores for certain Audi, BMW, and Rolls Royce models through its partnership with Autoliv Electronics, a supplier of automotive safety equipment. The Company offers an integrated suite of maritime electronics that utilizes multifunction displays, infrared cameras, depth sounders, GPS, auto pilots, and advanced command and control software.
The Company is engaged in providing advanced thermal imaging technology for consumer applications. It�� easy to use, affordable, and lightweight personal vision thermal cameras give people the ability to see at night. In the home, its cameras can be used for numerous household and security applications, such as locating heat leaks, evaluating insulation coverage, detecting water damage, identifying intruders, and locating pests. The Company supplies hand-held systems to the law enforcement market. The Company supplies cooled and uncooled camera cores, sensors, and readout integrated circuits on an OEM basis for a range of applications where customers require a product at a lower level of integration than a fully developed thermal imaging system.
In Thermal Measurement Markets thermal imaging systems are used for monitoring the condition of mechanical and electrical equipment. The company�� systems provide the ability to view thermal distribution in real time for products ranging in size from small hybrid integrated circuits to jet engines. Common applications include product development of microelectronics, cell phones, laptop computers, telecommunications equipment, consumer appliances, automotive components, and aircraft engines. Systems used in research and development applications require high imaging performance and measurement precision, coupled with extensive analysis and reporting software. Thermal imaging applications for manufacturing process control include applications where temperature consistency is critical, including monitoring the quality of metal, plastic and glass cast parts, which are highly depend! ent upon ! the temperature distribution in the mold; monitoring the quality of paper, which is dependent upon proper and even moisture distribution during the drying process; and monitoring the quality of products such as rubber gloves, which can be thermally examined to locate abnormally warm or cool spots, indicating non-uniform thickness that may result in a quality defect.
Infrared imagers can detect missing insulation, electrical faults, water intrusion and pest infiltration, can gauge energy efficiency, and can help detect the presence of moisture. Market segments include building diagnostics, energy auditing and home inspection, property and facility management, HVAC and plumbing, and moisture detection and restoration. Specially designed infrared systems can detect and image hydrocarbon gas emissions or leaks. It supplies trade professionals a range of test equipment to deliver high accuracy readings for the measurement of electricity, light, sound, temperature, humidity, airflow, revolutions per minute, and water quality. The Company offers fee-based training on the principles of thermography and the use of its products through ITC, its Infrared Training Center, which provides instruction, training, certification and applications engineering from several FLIR locations or at the customer�� site. It also licenses Infrared Training Centers to third parties in certain countries.
The Company competes with Danaher (Fluke), General Dynamics (Axsys), L-3 Communications, Sofradir (ULIS), Axis Communications, NEC and Testo.
Raymarine
Raymarine is a provider of marine electronics, and continues as a pioneer in the technologies that give boaters confidence on the water. The products that Raymarine develops and markets is intended to fulfill all of the marine electronic needs of recreational boaters and offer best-in-class integrated control solutions for all of their on-board instrumentation. Raymarine designs, develops, and markets electronics for the maritime market a! nd is a p! rovider of fully integrated stem to stern networked electronic systems for boats of many sizes. The business distributes its products through a network of independent distributors and retailers, as well as through its relationships with boat builders, providing both first fitment and aftermarket solutions.
The Company competes with Furuno, Garmin and Navico.
Surveillance
Surveillance focuses on providing enhanced vision and detection capabilities to a range of military, paramilitary, law enforcement, public safety, and other government customers. Its systems typically provide the capability to see over long distances, day or night, through adverse weather conditions, and from a range of vehicle, man portable, and fixed installation platforms. Typical applications include intelligence, surveillance, and reconnaissance (ISR), force protection, drug interdiction, search and rescue, special operations, and target designation. Surveillance products are sold off-the-shelf or can be customized for specific applications and frequently incorporate additional sensors, including visible light cameras, radars, low light cameras, laser rangefinders, laser illuminators, and laser designators.
Surveillance offers a range of products across multiple applications. For airborne applications, it has developed highly stabilized platforms, known as gimbals, which typically contain multiple payloads in addition to the infrared imaging system, as well as sophisticated software and analytic capabilities. For land applications, it manufactures three types of products: hand-held products, platform mounted products, and targeting products. Platform mounted surveillance systems include imaging and radar solutions, which are typically housed in a weather-tight enclosure and feature remote control capabilities and multi-sensor integration capability. Hand-held products are ruggedized and have optional lenses and target location capabilities. Ground-based targeting products are designed t! o attach ! to existing daylight sights to provide bore-sighted, nighttime capabilities. For maritime applications, it manufacture shipborne products which are similar to its airborne gimbals, but are inverted and customized for the marine environment.
In Search and Rescue market thermal imaging systems are used in airborne nd shipborne search and rescue missions to rescue individuals in danger or distress on boats or vehicles, or wounded or lost in adverse conditions. Such systems are in use by organizations such as the United States Army, United States Coast Guard, the United States Marine Corps, the United States Air National Guard, and the United Kingdom Ministry of Defense. In Border and Maritime Patrol market thermal imaging systems are used in airborne, shipborne, hand-held and fixed installation applications for border and maritime surveillance, particularly at night, to enforce borders and coastal waters, to monitor national fishing boundaries and to prevent smuggling. Its cameras are deployed along numerous borders worldwide, including in the United States, Europe and the Middle East. In Surveillance and Reconnaissance market Thermal imaging systems are used in surveillance and reconnaissance applications for the precise positioning of objects or people from substantial distances and for enhanced situational awareness, particularly at night or in conditions of reduced or obscured visibility. It also offers high-resolution frequency-modulated continuous wave radars that enable wide-area surveillance capable of detecting potential threats before they cross a perimeter. These systems can be installed on fixed platforms, manned mobile platforms, and unmanned aerial vehicles.
The Company supplies airborne thermal imaging systems for federal, state, and local law enforcement agencies. Agencies with this type of equipment have the ability to track suspects, locate lost persons, and provide situational awareness to officers on the ground. It offers several products that provide precise t! arget loc! ation and designation capabilities in applications ranging from clip-on rifle scope devices to high-precision, stabilized, airborne laser designator systems. Thermal imaging systems enable government agencies to expand their drug interdiction and support activities by allowing greater surveillance and detection capabilities. The Company�� systems are in use by the United States Customs Service, the United States Drug Enforcement Agency and the United States Federal Bureau of Investigation, as well as by foreign government agencies.
The Company competes with BAE Systems, DRS (a Finmeccanica company), Elbit Systems, General Dynamics, L-3 Communications, Lockheed Martin, Raytheon, Sagem, Sofradir, and Thales.
Detection
The Company�� Detection segment provides capabilities in the development of advanced sensor technologies used to detect and identify CBRNE threats. The Detection segment is focused on developing technologies and products to penetrate a global market for advanced threat detection capabilities. Detection manufactures and markets the portable explosive detector, the smallest spectroscopic radiation detector, and the smallest hand-held Raman sensor.
The Company offer both indoor and outdoor biological air monitors that are used by various governmental agencies, including the United States Department of Defense, airport authorities, and the National Park Service, for layered security at facilities and events. Its explosives detection products are used to identify military-grade explosives and homemade explosive devices in a range of military and public safety applications, such as screening high-risk individuals at checkpoints, identifying improvised explosive device (IED) makers, and screening air passengers and baggage. Its radiation products protect the public by warning of radionuclide exposure and have been or are being used by the U.S. Department of Energy�� Nuclear Emergency Search Team, the New York Police Department, the Internat! ional Ato! mic Energy Agency, the U.S. Coast Guard, and the United Kingdom�� Home Office Border and Immigration Agency.
The Company competes with Agilent Technologies, Canberra Industries, Idaho Technologies, NUCSAFE, SAIC, Smiths Detection, Thermo Fisher Scientific, and United Technologies.
Integrated Systems
Integrated Systems develops platform solutions for combating sophisticated security threats and incorporates multiple sensor systems in order to deliver actionable intelligence for wide area surveillance, intrusion detection, border security, and facility security. Integrated Systems incorporates advanced sensors from both the FLIR product suite and external vendors in order to design and manufacture adaptive and effective force protection, homeland security, and commercial solutions that are designed to save lives and protect critical assets. Integrated Systems utilizes an array of sensor technologies, such as radars, thermal imaging and visible light cameras, chemical detectors, radiation detectors, and command and control systems, provided by its other segments as well as from external parties, to create high value solutions for customers across the world.
Integrated Systems manufactures and markets several accurate mobile and fixed solutions for perimeter surveillance. The Cerberus mobile unmanned towers and manned SkyWatch towers are utilized for protecting borders, securing facilities, protecting forces, and safeguarding the public. These tower systems can be deployed in almost any environment and are fully networkable platform solutions that integrate various sensor suites, including infrared thermal or visible light cameras, ground surveillance radar, video motion detection, and unattended ground sensors. In addition, Integrated Systems offers open-source software that enables customers to command, control, and monitor their sensor networks. Cohesion is a flexible integration software enabling CBRNE sensors to be incorporated into standard command! and cont! rol software systems and is specifically designed to support or integrate with its or third-party advanced sensors and devices. Cameleon video integration software allows for advanced monitoring and control of video surveillance camera networks.
The Company competes with Boeing, Cobham, Honeywell, L-3 Communications, Lockheed Martin, Northrup Grumman, Raytheon, SAIC, Telephonics, and Thales.
Advisors' Opinion:- [By Rich Smith]
The Department of Defense issued 14 separate contract awards Tuesday, totaling just over $880 million in combined value. Among publicly traded U.S. defense contractors, a few of the notable winners were:
- [By Sue Chang and Saumya Vaishampayan]
Flir Systems Inc. (FLIR) �shed 5.3%. The maker of imaging and observation sensors said Friday its fourth-quarter earnings came in at 20 cents a share, falling short of the average estimate of 23 cents a share.
- [By Rich Smith]
The Department of Defense issued $312.5 million worth of new contract awards Monday. Notable winners included subsidiaries of two major defense contractors, FLIR Systems (NASDAQ: FLIR ) and General Dynamics (NYSE: GD ) .
- [By Sue Chang and Saumya Vaishampayan]
Flir Systems Inc. (FLIR) rallied 9.7% following the release of several new products at CES, including a thermal imaging system for smartphones.
Top 10 Warren Buffett Companies To Invest In 2014: Guggenheim Multi-Asset Income ETF (CVY)
The Guggenheim Multi-Asset Income ETF (the Fund), formerly Claymore/Zacks Multi-Asset Income Index ETF, seeks investment results that correspond generally to the performance of an equity index called the Zacks Multi-Asset Income Index (the Index). The Index consists of approximately 125 to 150 securities selected, based on investment and other criteria, from a universe of domestic and international companies. The universe of securities within the Index includes United States-listed common stocks, American depositary receipts (ADRs) paying dividends, real estate investment trusts, master limited partnerships, closed-end funds and traditional preferred stocks. The companies in the universe are selected using a methodology developed by the index provider, Zacks Investment Research, Inc. The Fund, using a passive or indexing investment approach, seeks to replicate the performance of the Index. The Fund�� investment advisor is Claymore Advisors, LLC. Advisors' Opinion:- [By Genia Turanova]
Moreover, investors can do one-stop shopping for most income classes through a single ETF as well. One interesting choice here is Guggenheim Multi-Asset Income (CVY).
Top 10 Warren Buffett Companies To Invest In 2014: Greengro Technologies Inc (GRNH)
GreenGro Technologies Inc., formerly Authoriszor Inc., provides management services for the planning, construction, staffing and operation of medical marijuana dispensaries, and nurseries on behalf of non-profit patient co-operatives. Through long term contracts, the Company operates non-profit centers, returning all unused patient contributions, on a pro-rata basis to each co-op member in the form of additional product. In February 2010, Authoriszor Inc. completed the acquisition of GreenGro Technologies, Inc., and CannovaHealth, a clinic management company. In September 2011, the Company acquired Vertical Hydrogarden, Inc.
Medical marijuana (medical cannabis) is an alternative method to other forms of medication used to manage or alleviate pain without the undo side-effects caused by the prescription medication being used to treat an illness. The Company stands ready to assist in patient care co-operatives throughout the United States.
Advisors' Opinion:- [By Dan Burrows]
MediSwipe (MWIP) has tripled, with MWIP stock up 200%. Cannabis Science (CBIS) is closing in on quadrupling, as CBIS stock gained 273%. And GreenGro Technologies (GRNH)? Brace yourself, because GRNH stock is up over 1,000% … including an 18% so far today.
- [By James E. Brumley]
If it seems like the buzz surrounding marijuana stocks like Medical Marijuana Inc. (OTCMKTS:MJNA), Hemp, Inc. (OTCMKTS:HEMP), and GreenGro Technologies, Inc. (OTCMKTS:GRNH) has been a little louder than usual the last few days, you're not crazy - it has been louder, and particularly bullish. GRNH shares advanced 37% in December. HEMP is up 166% for the past two weeks. MJNA has jumped 47% in just the past couple of days. Well, as it turns out, it's not just mere coincidence that GreenGro Technologies, Hemp, Medical Marijuana, and a bunch of other cannabis-related names have perked up of late. And, odds are pretty good they'll all continue to do well (even of the pace slows a bit) in 2014.
- [By Ben Levisohn]
But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).
Top 10 Warren Buffett Companies To Invest In 2014: OncoGenex Pharmaceuticals Inc.(OGXI)
OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company?s clinical stage products include Custirsen, a phase III clinical stage product for treatment in men with metastatic castrate-resistant prostate cancer; OGX-427, which is in phase II clinical development stage is designed to inhibit heat shock protein 27; and SN2310 that completed phase I stage of clinical development is designed to evaluate safety in patients with advanced cancer. Its pre clinical stage products include GX-225 that is focused on reducing the production of IGFBP-2 and IGFBP-5; and CSP-9222, lead compound from a family of caspase activators. OncoGenex Pharmaceuticals, Inc. is based in Bothell, Washington.
Advisors' Opinion:- [By John McCamant]
2014 is shaping up to be the most important year for OncoGenex Pharmaceuticals (OGXI), and, we believe, it can very well represent a major inflection point for the company with positive Synergy results.
Top 10 Warren Buffett Companies To Invest In 2014: New Residential Investment Corp (NRZ)
New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate. On May 15, 2013, Newcastle Investment Corp. announced that the spin-off of New Residential Investment Corp.
The Company is managed by an affiliate of Fortress Investment Group LLC, a global investment management. The Company primarily target investments in excess mortgage servicing rights, residential mortgage backed securities, residential mortgage loans and other related investments.
Advisors' Opinion:- [By Lauren Pollock]
New Residential Investment Corp.(NRZ) and other investors agreed to buy about $3.2 billion of servicing advances from Nationstar Mortgage Holdings Inc.(NSM), part of Nationstar’s plan to reconfigure its acquisition structure. The advances relate to nonagency residential mortgage loans with an unpaid principal balance of about $58 billion. Nationstar shares rose 4.1% to $42.50 in light premarket trading.
Top 10 Warren Buffett Companies To Invest In 2014: Signet Jewelers Limited(SIG)
Signet Jewelers Limited operates as a specialty jewelry retailer in the United States, the United Kingdom, the Republic of Ireland, and the Channel Islands. The company retails jewelry, watches, and associated services. As of January 28, 2012, it operated a network of 1,318 stores in 50 states in the United States that trade nationally in malls and off-mall locations as ?Kay Jewelers?, and regionally under various mall-based brands, as well as operated as destination superstores under the ?Jared The Galleria Of Jewelry? trade name. The company also operated a network of 535 stores in the United Kingdom, including 14 stores in the Republic of Ireland and 3 in the Channel Islands under the ?H.Samuel?, ?Ernest Jones?, and ?Leslie Davis? trade names in high street locations and shopping malls. Signet Jewelers Limited was founded in 1950 and is based in Hamilton, Bermuda.
Advisors' Opinion:- [By John Kell]
Signet Jewelers Ltd.(SIG) agreed to buy smaller rival Zale for about $690 million, significantly expanding the jewelry retailer’s presence in North America. Signet will offer $21 in cash for each Zale share, representing a 41% premium over Tuesday’s closing price. Zale shares jumped to $20.87 premarket and Signet climbed 12% to $88.40.
- [By Jake L'Ecuyer]
Top Headline
Signet Jewelers (NYSE: SIG) announced its plans to buy Zale (NYSE: ZLC) for around $690 million. Signet will pay $21 per share to acquire Zale, representing a 41% premium to Zale's closing price of $14.91 on Tuesday. - [By Dan Moskowitz]
Peer comparisons
It's clear that Zale has potential going forward, but while past performance doesn't guarantee future results, it's often a very good indicator of management capabilities. With that in mind, consider the revenue performance for Zale compared to that of�Tiffany (NYSE: TIF ) , as well as Signet Jewelers (NYSE: SIG ) , over the past five years: - [By Seth Jayson]
Signet Jewelers (NYSE: SIG ) reported earnings on May 23. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended May 4 (Q1), Signet Jewelers missed estimates on revenues and beat slightly on earnings per share.
Top 10 Warren Buffett Companies To Invest In 2014: Salix Pharmaceuticals Ltd (SLXP)
Salix Pharmaceuticals, Ltd., incorporated on December 31, 2001, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company�� products included XIFAXAN, MOVIPREP, APRISO, RELISTOR, OSMOPREP, SOLESTA, DEFLUX, FULYZAQ, GIAZO, METOZOLV ODT, AZASAN, ANUSOL-HC, PROCTOCORT, PEPCID, DIURIL and COLAZAL. As of December 31, 2012, its primary product candidates under development included Rifaximin, Methylnaltrexone bromide oral, Budesonide foam and Rifaximin EIR. In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.
Xifaxan (rifaximin) tablets
Xifaxan is a gastrointestinal-specific oral antibiotic. The Food and Drug Administration ( FDA) approved Xifaxan 200 milligram for the treatment of patients 12 years of age and older with travelers��diarrhea caused by noninvasive strains of E coli. Xifaxan 550 milligram was approved by the FDA for reduction in risk of overt hepatic encephalopathy (HE), recurrence in patients 18 years of age or older.
It launched Xifaxan 200milligram in the United States and Xifaxan 550 milligram using its own direct sales force. The Company is exploring potential additional indications, formulations, clinical trials and co-promotion arrangements to capitalize on the potential for Xifaxan, including its development program in irritable bowel syndrome.
In October 2012, the USPTO declared an interference action to determine the priority of invention between Cipla�� application related to amorphous rifaximin and Solmag SpA�� application directed to amorphous rifaximin. In February 2012, the FDA posted draft bioequivalence guidance for rifaximin 550 milligram tablets. The draft guidance for rifaximin 550 milligram tablets recommends that in addition to conducting the program outlined in the FDA posted ! draft guidance document for rifaximin 200 milligram tablets discussed above, a single-dose, three-way crossover in-vivo study of fasting bioequivalence with pharmacokinetic endpoints in both fasting and fed states be performed in the 550 milligram tablets. Additionally, the guidance stipulated that the formulation of the 550 milligram strength should be proportionally similar to that of the 200 milligram strength in order to file an ANDA for approval of a generic rifaximin 550 milligram tablet for the treatment of hepatic encephalopathy.
MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) oral solution
MoviPrep is a patent-protected, liquid polyethylene glycol-salt, or PEG, bowel cleansing product that the FDA approved. MoviPrep is indicated for bowel cleansing prior to colonoscopy, intestinal surgery and barium enema X-ray examinations.
Apriso (mesalamine) extended-release capsules 0.375 gram
Apriso is a locally-acting aminosalicylate and is the only delayed and extended release mesalamine product approved by the FDA for once-a-day dosing for the maintenance of remission of ulcerative colitis. Apriso is designed to provide for the distribution of the active ingredient beginning in the small bowel and continuing throughout the colon. The product�� prolonged release mechanism might allow them to expand the range of treatment options for ulcerative colitis.
Relistor (methylnaltrexone bromide)
Relistor Subcutaneous Injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Relistor is approved for use in over 55 countries worldwide.
OsmoPrep and Visicol (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP) tablets
Visicol and OsmoPrep tablets are indicated for clean! sing of t! he colon as a preparation for colonoscopy in adults 18 years of age or older. Visicol and OsmoPrep are the only, tablet bowel cleansing products approved by the FDA and marketed in the United States. OsmoPrep is a patented, second-generation tablet bowel cleansing product that the FDA approved. OsmoPrep offers potential benefits compared to Visico,l such as its lack of microcrystalline cellulose, smaller tablet size and possible lower dose administration.
Solesta
Solesta is a biocompatible tissue bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. Solesta is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy, such as diet, fiber therapy and/or anti-motility medications. It is the only injectable gel for this indication to be administered in an outpatient setting without the need for surgery or anesthesia.
Deflux
Deflux is a medical device indicated for children affected by Grades II-IV vesicoureteral reflux, a malformation of the urinary bladder that can result in severe infections of the kidneys and irreversible kidney damage. Deflux was granted premarket approval application (PMA) approval, and has been on the market in the United States.
Fulyzaq (crofelemer) delayed-release tablets
On December 31, 2012, the FDA granted marketing approval for this product, under the trade name Fulyzaq. Fulyzaq is indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Fulyzaq should also be eligible for five years of marketing exclusivity from the date of FDA approval, and the product might be entitled to patent term restoration.
Giazo (balsalazide disodium) tablets
February 3, 2012, the FDA granted marketing approval for this product under the trade name Giazo. Giazo is indicated for the treatment of mildly to moderately active ulcerative col! itis in m! ale patients 18 years of age and older. It shipped Giazo to wholesalers in 2012.
Metozolv ODT (metoclopramide hydrochloride) 5 milligrams and 10 milligrams orally disintegrating tablets
METOZOLV ODT is indicated for the relief of symptomatic gastroesophageal reflux or short-term (4-12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy and diabetic gastroparesis or the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis.
Azasan (azathioprine) tablets
Azasan is an FDA-approved drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. It launched the 75 and 100 milligrams dosage strengths of Azasan in the United States.
Anusol-HC and Proctocort (hydrocortisone) creams and suppositories
The Company acquired the right to sell Anusol-HC 2.5% (hydrocortisone USP) cream, Anusol-HC 25 milligrams (hydrocortisone acetate) rectal suppositories, Proctocort 1% (hydrocortisone USP) cream and Proctocort 30 mg (hydrocortisone acetate) rectal suppositories from King Pharmaceuticals, Inc. The two cream products are topical corticosteroids indicated for relief of the inflammatory and pruritic, or itching, manifestations of corticosteroid-responsive dermatoses. The two suppository products are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and other inflammatory conditions.
Pepcid (famotidine) for Oral Suspension and Diuril (Chlorothiazide)
Pepcid Oral Suspension is a widely known prescription pharmaceutical product indicated for several gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer and gastro-esophageal reflux disease. Pepcid Oral Suspension and Diuril Oral Suspension, both liquid form! ulations ! of their solid dosage form counterparts, compete in a combined annual United States market concentrated in pediatric and hospitalized patient populations.
Colazal (balsalazide disodium) capsules
The Company launched Colazal to physicians in the United States. FDA approved Colazal for use in pediatric patients between 5 to 17 years of age with ulcerative colitis. The pediatric use of Colazal has been granted orphan drug designation. The Office of Generic Drugs, or OGD, approved three generic balsalazide capsule products.
The Company competes with GlaxoSmithKline plc, Giuliani S.p.A., Axcan Pharma, Inc., Abbott Laboratories, Warner Chilcott plc, Shire Pharmaceuticals Group plc, Pharmacia & Upjohn, Inc., Alaven Pharmaceutical LLC, Ferring Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Cumberland Pharmaceuticals, Inc, Prometheus Laboratories, Inc., Ranbaxy Pharmaceuticals, Ferndale Laboratories, GATE Pharmaceuticals , Nycomed , Medtronic, Inc., and Cubist Pharmaceuticals, Inc.
Advisors' Opinion:- [By Eric Volkman]
McGraw-Hill Financial's S&P Dow Jones Indices is making several adjustments to a pair of its signature products. On July 30 after market close, the S&P MidCap 400 will be the new home of Salix Pharmaceuticals (NASDAQ: SLXP ) , which advances from the S&P SmallCap 600 to replace Gardner Denver (NYSE: GDI ) . The latter company agreed to be acquired by KKR earlier this month.
Top 10 Warren Buffett Companies To Invest In 2014: BreitBurn Energy Partners L.P.(BBEP)
BreitBurn Energy Partners L.P. engages in the acquisition, exploitation, and development of oil and gas properties in the United States. The company?s properties include natural gas, oil, and midstream assets comprising fields in the Antrim Shale in Michigan, and the New Albany Shale in Indiana and Kentucky; and fields in the Evanston and Green River basins in southwestern Wyoming, the Wind river and Big Horn basins in central Wyoming, the Powder River basin in eastern Wyoming, the Los Angeles basin in California, and fields in Florida?s Sunniland Trend. As of December 31, 2011, its total estimated proved reserves were 151.1 million barrels of oil equivalent. BreitBurn GP, LLC serves as the general partner to the company. BreitBurn Energy Partners L.P. was founded in 2006 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By Matt DiLallo]
There's no doubt about it that last quarter wasn't a barn burner. LINN pointed out a number of reasons why it missed its quarterly production guidance which caused it to miss earnings this quarter. What would be most worrisome is that LINN's distribution coverage ratio slipped to 0.88 times, meaning LINN paid out more than it should on the quarter; however, that concern will soon abate. Further, LINN is not the only upstream MLP that had trouble in the quarter, as BreitBurn's (NASDAQ: BBEP ) coverage ratio slipped all the way to 0.67 times, which was well below its target ratio of 1.1-1.2 times. LINN and its peers face a real uphill battle in keeping that distribution stable, let alone growing it.
- [By Robert Rapier]
One of Memorial’s advantages is the lowest total cost of production among peers. (Note that some of the higher cost producers extract a higher percentage of higher-value liquids.) Memorial’s debt level is comparable to upstream competitors like BreitBurn Energy Partners (Nasdaq: BBEP). Like LRR Energy, Memorial is significantly hedged, with extensive hedging protecting significant cash flow through 2019.
No comments:
Post a Comment